KPIs & Operating Metrics(New)
Biologics And Drug Delivery Revenue By CategoryBiologics And Drug Delivery Revenue By Category AnnualBreakdown Of AssetsCapital Equipment And Software Revenue By CategoryCapital Equipment And Software Revenue By Category AnnualCost Of RevenueDeferred RevenueEmployee StatisticsFunctional Neurosurgery Navigation And Therapy Revenue By CategoryFunctional Neurosurgery Navigation And Therapy Revenue By Category AnnualGross Margin %Gross ProfitOpex As A % Of Total Revenue %OPEX SegregationProfitabilityProfitability %Profitability AnnualProfitability Annual %Property And Equipment, Net BreakdownRemaining Performance ObligationsRemaining Performance Obligations AnnualRevenue By Business Vertical AnnualRevenue By Business Vertical Annual %Revenue By SegmentRevenue By Segment %Revenue By Segment AnnualRevenue By Segment Annual %Revenue By Service LineRevenue By Service Line %Revenue By Service Line AnnualRevenue By Service Line Annual %
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

ClearPoint Neuro (CLPT) Cost Of Revenue (2018 - 2025)

Historic Cost of Revenue for ClearPoint Neuro (CLPT) over the last 13 years, with Q3 2025 value amounting to $3.8 million.

  • ClearPoint Neuro's Cost of Revenue rose 814.31% to $3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $15.5 million, marking a year-over-year increase of 1052.78%. This contributed to the annual value of $14.5 million for FY2024, which is 1495.04% up from last year.
  • According to the latest figures from Q3 2025, ClearPoint Neuro's Cost of Revenue is $3.8 million, which was up 814.31% from $4.0 million recorded in Q2 2025.
  • Over the past 5 years, ClearPoint Neuro's Cost of Revenue peaked at $4.0 million during Q2 2025, and registered a low of $1.6 million during Q1 2021.
  • Over the past 5 years, ClearPoint Neuro's median Cost of Revenue value was $2.9 million (recorded in 2023), while the average stood at $2.9 million.
  • Over the last 5 years, ClearPoint Neuro's Cost of Revenue had its largest YoY gain of 10022.15% in 2021, and its largest YoY loss of 2154.29% in 2021.
  • Over the past 5 years, ClearPoint Neuro's Cost of Revenue (Quarter) stood at $2.2 million in 2021, then increased by 17.44% to $2.5 million in 2022, then soared by 32.19% to $3.3 million in 2023, then grew by 13.68% to $3.8 million in 2024, then increased by 0.87% to $3.8 million in 2025.
  • Its last three reported values are $3.8 million in Q3 2025, $4.0 million for Q2 2025, and $3.8 million during Q1 2025.